RT Journal Article
SR Electronic
T1 Neura: a specialized large language model solution in neurology
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.11.24302658
DO 10.1101/2024.02.11.24302658
A1 Barrit, Sami
A1 Torcida, Nathan
A1 Mazeraud, Aurélien
A1 Boulogne, Sébastien
A1 Benoit, Jeanne
A1 Carette, Timothée
A1 Carron, Thibault
A1 Delsaut, Bertil
A1 Diab, Eva
A1 Kermorvant, Hugo
A1 Maarouf, Adil
A1 Slootjes, Sofia Maldonado
A1 Redon, Sylvain
A1 Robin, Alexis
A1 Hadidane, Sofiène
A1 Harlay, Vincent
A1 Tota, Vito
A1 Madec, Tanguy
A1 Niset, Alexandre
A1 El Hadwe, Salim
A1 Massager, Nicolas
A1 Lagarde, Stanislas
A1 Carron, Romain
YR 2024
UL http://medrxiv.org/content/early/2024/02/13/2024.02.11.24302658.abstract
AB Large language models’ (LLM) ability in natural language processing holds promise for diverse applications, yet their deployment in fields such as neurology faces domain-specific challenges. Hence, we introduce Neura: a scalable, explainable solution to specialize LLM. Blindly evaluated on a select set of five complex clinical cases compared to a cohort of 13 neurologists, Neura achieved normalized scores of 86.17% overall, 85% for differential diagnoses, and 88.24% for final diagnoses (55.11%, 46.15%, and 70.93% for neurologists) with rapid response times of 28.8 and 19 seconds (9 minutes and 37.2 seconds and 8 minutes and 51 seconds for neurologists) while consistently providing relevant, accurately cited information. These findings support the emerging role of LLM-driven applications to articulate human-acquired and integrated data with a vast corpus of knowledge, augmenting human experiential reasoning for clinical and research purposes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.